Trial Scout

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

Study Location

Southtowns Gastroenterology

ClinicalTrials.gov Identifier: NCT03464097
Recruitment Status: Recruiting
First Posted: 3/13/2018 12:00:00 AM
Last Update Posted: 3/15/2019 12:00:00 AM

Study Description

Eligibility Criteria

Additional Contacts

Brief Summary

A PHASE 3, MULTI CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ORAL OZANIMOD AS MAINTENANCE THERAPY FOR MODERATELY TO SEVERLY ACTIVE CROHN's DISEASE

Condition or Disease

Crohn Disease

Intervention/Treatment

Other: Placebo / Placebo

Phase

Phase 3

Detailed Description

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Go to ClinicalTrials.gov >